Research and Development

The year is flying by – it’s another Friday, and that means another Top Ten run-down.Perhaps the biggest story this …

Pfizer has revealed new Phase 3 data for its oral epilepsy therapy Lyrica (pregbalin) as an adjunctive treatment for partial …

A team of researchers from the University of Cambridge and Warwick Clinical Trials have revealed that Roche’s Herceptin is just …

Samantha O’Shea explains some of the challenges she faces caring for her son, Ethan, who lives with a debilitating but …

Eli Lilly has released new Phase 3 results for its CGRP inhibitor galcanezumab in the treatment of episodic cluster headache, …

The saga of Novartis’ ill-advised $1.2 million deal with US President Donald Trump’s lawyer Michael Cohen continues to unfold as …

Pfizer’s Retacrit (epoetin alfa-epbx), a biosimilar version of Amgen’s Epogen and Janssen’s Procrit, has been approved for use in the …

Researchers from Imperial College London have discovered how to interfere with one of the building blocks that allows the common …

We are in the midst of a breath-taking series of changes in the world of pharmacovigilance, both within Europe and …

Researchers from the University of Texas MD Anderson Cancer Center have been developing and testing a new model for the …

Asymptomatic carriers of malaria may be responsible for the onwards transmission of up to 90% of cases, highlighting the importance …

Patient-reported outcomes are becoming increasingly respected and valued by clinical professionals in the pursuit of improving treatment outcomes, but their …

Medigene has announced that it has bolstered the existing partnership it has in place with US firm bluebird bio, originally …

Akari has lost its second CEO in 12 months after David Horn Solomon was accused of misusing the company credit …